论文部分内容阅读
【目的】探讨超声乳化透明晶状体摘除联合后房人工晶体植入治疗高度近视的临床效果。【方法】52例(62眼)屈光度超过-10 D以上的高度近视病人采用超声乳化晶体摘除人工晶体植入,术后定期随访观察视力改善情况。【结果】52例(62眼)高度近视病人术后平均随访12个月,术后裸眼视力≤0.1 10眼,0.1~0.5者31眼,0.5~1.0者21眼,矮正视力≤0.1者4眼,0.1~0.5者33眼,0.5~1.0者25眼,较术前均显著提高。【结论】超声乳化透明晶状体摘除人工晶体植入是治疗高度近视安全有效的方法。
【Objective】 To investigate the clinical effect of phacoemulsification combined with posterior chamber intraocular lens implantation in the treatment of high myopia. 【Methods】 Thirty-two cases (62 eyes) of high myopia with diopter above -10 D were treated with phacoemulsification and intraocular lens implantation. The visual acuity was observed after regular follow-up. 【Results】 52 cases (62 eyes) of high myopia patients were followed up for an average of 12 months. The postoperative uncorrected visual acuity was less than or equal to 0.1 10 eyes, 0.1 to 0.5 eyes were 31 eyes, 0.5 to 1.0 eyes were 21 eyes, short-sightedness was less than or equal to 0.1 eyes 4 Eyes, 0.1 ~ 0.5 were 33 eyes, 0.5 ~ 1.0 were 25 eyes, compared with preoperative significantly increased. 【Conclusions】 Phacoemulsification and intraocular lens implantation is a safe and effective method for the treatment of high myopia.